Partsol, the global leader in Cognitive AI and creator of the proprietary Absolute Truth algorithms, proudly announces a groundbreaking innovation in artificial intelligence: AI Stem Cells. This ...

The higher efficiency achieved using early embryonic blastomeres for cloning reported in early experiments may be attributable to the higher proportion of donor cells in an undifferentiated stage ...

Here, we used deep full-length single-cell RNA-sequencing to distinguish post-mitotic cone and rod developmental states and cone-specific features that contribute to retinoblastomagenesis. The ...

Here, we report a systematic transcriptional atlas to delineate molecular and cellular heterogeneity in GA using single-cell RNA sequencing (scRNA-seq). Design We performed unbiased transcriptome-wide ...

Blocking the METTL3 protein can increase sensitivity to chemotherapy in neuroblastoma, according to new research. The study shows how specific RNA modifications affect gene expression in the early ...

This image provided by Ana-Maria Cujba shows blood vessels in a portion of the human small intestine, March 21, 2024. (Ana-Maria Cujba/Wellcome Sanger Institute via AP) This image provided by Nathan ...

Join Dr. George Muñoz, MD, Rheumatologist and Internist, The Institute for Functional Medicine; and Dr. Andrew Concoff, MD, Rheumatologist and Chief Innovation Officer, Exagen Inc., for the live ...

An ambitious plan to map all 37 trillion cells in the human body is transforming understanding of how our bodies work, scientists report. The received wisdom said we were built from around 200 ...

A new study has shown that adding a drug called pembrolizumab to standard treatments can improve survival for people with certain sarcomas.

MAI Capital Management lessened its stake in BioAtla, Inc. (NASDAQ:BCAB – Free Report) by 5.3% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission.